HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Clarins Adds “Shimmering” Pastels To Its Color Story For Spring 2007

This article was originally published in The Rose Sheet

  • News

Executive Summary

Clarins has retooled its color cosmetics line for spring, focusing on "highlighting and enhancing, enchanting and savoring beauty," the French cosmetics firm says

You may also be interested in...



Clarins Emphasizes Total Pollution Protection With Expertise 3P Launch

Expertise 3P, a spray designed to protect skin from pollution and electromagnetic waves, was introduced by Clarins Nov. 16 in New York City

Clarins Updates Sun Care Items, Unveils Lip Colour Tint

Clarins is launching Sun Wrinkle Control Eye Contour Cream SPF 30, positioned as the "first cosmetic sunglasses" for eyes, the French beauty company said

Clarins Super Restorative Serum Debuts With Brand’s Highest Price Point

Clarins Super Restorative Serum is bowing this fall priced at $110, representing a significant premium to the brand's existing skin care products

Table

View full table

Tags:
Latest Headlines

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation

Probiotics And Cold Remedies Boost Recordati In 2023

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

See All
UsernamePublicRestriction

Register

RS014365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By